Imagine a young girl in the bustling town of Mathura, Uttar Pradesh, back in the 1940s, gazing at the stars and dreaming of healing the world. That girl was Saroj Chooramani Gopal, born on July 25, 1944, into a time when women’s roles were often confined to the home. But Saroj? She had fire in her eyes and a stethoscope in her future. “Why can’t a girl become a doctor?” she’d challenge her family during dinner conversations, her voice steady amid the clinking of plates. Little did they know, she was about to shatter ceilings left and right. 0

Fast forward to the mid-1960s. Saroj enrolled at Sarojini Naidu Medical College in Agra—affectionately known as SN Medical College—a place teeming with ambitious minds but few women in surgery. Graduating in 1966 with her MBBS, she didn’t stop there. “Surgery? That’s for men,” some professors scoffed. But Saroj, with a mischievous grin, replied, “Watch me.” She became the first woman postgraduate student in general surgery at her college, earning her MS degree and proving that scalpels don’t discriminate. 4 5

Her thirst for knowledge led her to the prestigious All India Institute of Medical Sciences (AIIMS) in New Delhi, where she pursued an M.Ch in Paediatric Surgery. Picture this: in the operating theater, surrounded by skeptical colleagues, Saroj performed intricate procedures on tiny patients. “This child needs us now,” she’d say softly to her team, her hands steady as she pioneered techniques that saved countless young lives. In 1973, she made history as the first Indian woman to earn that super-specialty degree, becoming a beacon for aspiring female surgeons across the nation. 1 3 6

Dr. Gopal’s career blossomed like a lotus in the Ganges. She joined Banaras Hindu University (BHU) as a faculty member, rising through the ranks to head the Paediatric Surgery Department. Her days were a whirlwind of surgeries, teachings, and research—over 100 papers published on topics from neonatal care to innovative surgical methods. “Medicine isn’t just about cutting and stitching,” she’d tell her students in lively lectures. “It’s about empathy, innovation, and never giving up on a patient.” Her leadership extended to becoming the Vice Chancellor of King George’s Medical University in Lucknow, where she mentored generations and pushed for better medical education. 0 5

In 2013, the nation recognized her indomitable spirit with the Padma Shri, one of India’s highest civilian honors, for her contributions to medicine and education. “This award isn’t just for me,” she humbly said at the ceremony, “it’s for every woman who dares to dream big.” 0

But here’s where the story gets even more inspiring—Dr. Gopal proves age is just a number. At 79, in January 2024, she enrolled in a PhD program at IIT Kanpur, diving into stem cell research. Her focus? Harnessing cells from bone marrow or abdominal linings to revolutionize treatments. “Why stop learning now?” she quipped to reporters, her eyes twinkling. “Life’s too short not to chase new horizons.” Imagine her in IIT classrooms, surrounded by wide-eyed youngsters, sharing stories of her surgical triumphs while jotting notes on cutting-edge biotech. It’s a testament to her lifelong mantra: curiosity never retires. 2 4 7 8

Diving Deep into Dr. Saroj Chooramani Gopal’s Stem Cell Odyssey: From Healing Kids to Regenerating Spines

Picture this: It’s January 2024, and a 79-year-old trailblazer walks into the labs of IIT Kanpur, not as a guest lecturer, but as a wide-eyed PhD student. “Age? That’s just a number on my passport,” Dr. Saroj Chooramani Gopal might have chuckled to her supervisor, Prof. Ashok Kumar, as she rolled up her sleeves for her latest quest in stem cell research. This Padma Shri-awarded pediatric surgeon, fresh from decades of saving tiny lives, is now chasing the holy grail of regenerative medicine: using stem cells to mend damaged spinal cords. But her journey with stem cells didn’t start here—it’s a saga that’s been unfolding for over a decade, blending surgical grit with cutting-edge science. 1 2 20

Dr. Gopal’s romance with stem cells began during her tenure at Banaras Hindu University (BHU), where she wasn’t content with just operating—she wanted to innovate. “Why stop at fixing what’s broken when we can teach the body to heal itself?” she’d often muse in her lectures. Back in the early 2010s, she pioneered work on mesenchymal stem cells (MSCs), those versatile shape-shifters from bone marrow or fat tissue that can morph into various cell types. One of her standout contributions? The “Chooramani technique,” a novel method from 2013 where she transposed omentum (a fatty abdominal layer rich in blood vessels) onto injured spinal cords, combined with stem cell infusions. “It’s like giving the spine a nutrient-packed blanket,” she explained in a paper, showing how this could promote healing in traumatic injuries. This wasn’t just theory; in a 2015 randomized trial, she tested surgery plus omentoplasty and autologous bone marrow-derived mononuclear cells on spinal cord patients, reporting improved clinical outcomes like better sensation and mobility. “The results were promising,” she noted, “but we need more to make it mainstream.” 6 19 22

Her stem cell explorations didn’t stop at spines. Dr. Gopal turned her scalpel-sharp mind to diabetes and organ transplants too. In 2013, she co-authored a study on transforming adipose tissue (fat) into insulin-producing cells for type 1 diabetes patients. “Infuse these lab-grown cells, and watch blood sugar stabilize,” she’d say, detailing how two young patients reduced their insulin needs after treatment. Another gem: a 2014 paper on co-infusing donor-derived MSCs and hematopoietic stem cells in kidney transplants. “This combo minimizes immunosuppression drugs,” she argued, reducing rejection risks while letting patients thrive with fewer meds. Her work here earned nods from the medical community, with one study cited over 40 times, proving her ideas were sparking global conversations. 8 19 22

Fast-forward to her PhD at IIT Kanpur’s Biological Sciences and Bioengineering Department, where she’s a Distinguished Visiting Professor and PhD scholar in the AK BioLabs under Prof. Kumar. Her current obsession? Harnessing stem cells from bone marrow or the abdominal lining (peritoneum) to regenerate damaged spinal nerves. “Imagine a child paralyzed from a fall walking again,” she envisioned in interviews. The goal: Extract these autologous (patient’s own) cells, coax them to repair neural tissue, and tackle spinal injuries or vertebral damage that leave millions immobile. It’s neural tissue engineering at its finest—blending her surgical expertise with bioengineering to create therapies that could revolutionize rehab for kids and adults alike. As of early 2026, her research is ongoing, with no major breakthroughs publicly announced yet, but she’s stayed active. In August 2025, as Organizing Secretary for MIDNAMSCON 2025 (a convergence of medical and engineering minds), she rallied experts on topics like regenerative medicine, sharing her insights and inspiring the next gen. “We must draw from our traditions while pushing science forward,” she urged at a related event, her voice as steady as ever. 1 2 20 29 30

Dr. Gopal’s stem cell saga isn’t just about lab coats and petri dishes—it’s a testament to relentless curiosity. With over 100 papers in her career (many on stem cells racking up hundreds of citations), she’s bridged pediatrics, surgery, and biotech. “Learning never retires,” she quips, and at 81 now, she’s proving it daily. If her work pans out, it could mean hope for spinal injury victims worldwide. Who knows what breakthrough she’ll unveil next? One thing’s for sure: Dr. Gopal is rewriting the rules, one cell at a time.

Patient outcomes with the Chooramani technique come primarily from the original 2013 study published in the Asian Journal of Neurosurgery by Dr. GS Chooramani (Saroj Chooramani Gopal) and colleagues. This was a prospective series involving 16 patients with post-traumatic thoraco-lumbar spinal cord injury (SCI) leading to paraplegia. All underwent the single-staged omental transposition procedure, often as an adjunct to standard decompression and stabilization.

Key Safety and Procedural Outcomes

The technique shone in terms of safety and feasibility:

• No major complications reported in the series: Specifically, avoided common issues with traditional multi-staged omental transposition, such as wound infection, incisional hernia, CSF leak, pedicle compromise, or significant ischemia.
• Reduced operative time: Procedure completed in approximately 4 hours (roughly half the time of earlier two-staged methods, which often exceeded 8 hours).
• Minimal morbidity: The single-stage approach made it technically easier, with smoother mobilization of the vascularized omental flap and direct application to the injured cord after laminectomy and durotomy.

These factors positioned the Chooramani technique as a practical modification—reliable, quicker, and lower-risk for centers experienced in complex SCI surgery.

Neurological Outcomes

Neurological recovery was assessed using the ASIA (American Spinal Injury Association) Impairment Scale, a standard tool grading from A (complete injury, no motor/sensory function below the level) to E (normal).

• At 3-month follow-up:
• 1 patient improved from ASIA A (complete injury) to ASIA D (incomplete, with significant motor function preserved below the level).
• 2 patients improved from ASIA A to ASIA B (incomplete, with sensory but no motor function preserved below the level).
• The remaining patients showed no major change or only minor gains (the paper does not detail every case exhaustively, but emphasizes that improvements occurred in a subset).

The authors noted these gains as encouraging, especially given the typically poor spontaneous recovery in chronic or severe traumatic SCI with complete lesions. However, they stressed this was not a cure—outcomes varied, and the technique was presented as an adjunctive option to promote revascularization and potential neuroprotection rather than a standalone regenerative miracle.

Broader Context and Limitations

• The study did not include a control group in the 2013 paper, so direct comparison to standard care (decompression ± stabilization alone) is limited.
• In related work by the same team (e.g., a later randomized controlled trial around 2015–2019 combining omentoplasty with autologous bone marrow mononuclear cell infusion), combination approaches showed modestly better sensory/motor gains and functional improvements (e.g., increased bowel frequency in some), but the pure Chooramani omental transposition series stands as the core evidence for the technique itself.
• Long-term follow-up beyond 3 months isn’t detailed in the primary publication, and the approach remains niche—cited in reviews on omental applications in neurology (including 2021 animal studies validating omental benefits for nerve preservation and cavity reduction), but not yet a mainstream SCI therapy due to the overall challenges in reversing chronic spinal cord damage.

Dr. Gopal’s Perspective

Dr. Gopal has always framed this work humbly: “The omentum brings its own magic—blood supply, growth factors, anti-inflammatory power—but we must be realistic. For some patients, even small steps forward in sensation or incomplete recovery mean reclaiming dignity.” The technique’s real win? It made a promising biological adjunct safer and more accessible, paving the way for her ongoing stem cell explorations at IIT Kanpur to potentially amplify these effects.

In summary, the Chooramani technique delivered excellent procedural safety, shorter surgery, and modest but meaningful neurological improvements in a small cohort of severe SCI patients—enough to inspire further research, though larger, controlled trials would be needed to firmly establish its place in modern spine care. It’s a classic example of surgical innovation meeting regenerative hope in one of medicine’s toughest arenas.

From a defiant girl in Mathura to a Padma Shri-awarded pioneer and now a PhD candidate at IIT, Dr. Saroj Chooramani Gopal’s life is a riveting saga of resilience, innovation, and heart. She’s not just a doctor—she’s a force of nature, reminding us all: “The only limits are the ones we set ourselves.” If her story doesn’t inspire you to pick up a book or chase a dream, what will?